These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 10758914

  • 1. Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection.
    Monck MA, Mori A, Lee D, Tam P, Wheeler JJ, Cullis PR, Scherrer P.
    J Drug Target; 2000; 7(6):439-52. PubMed ID: 10758914
    [Abstract] [Full Text] [Related]

  • 2. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity.
    Saravolac EG, Ludkovski O, Skirrow R, Ossanlou M, Zhang YP, Giesbrecht C, Thompson J, Thomas S, Stark H, Cullis PR, Scherrer P.
    J Drug Target; 2000; 7(6):423-37. PubMed ID: 10758913
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
    Li W, Huang Z, MacKay JA, Grube S, Szoka FC.
    J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
    [Abstract] [Full Text] [Related]

  • 8. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
    Merdan T, Kunath K, Petersen H, Bakowsky U, Voigt KH, Kopecek J, Kissel T.
    Bioconjug Chem; 2005 Jan; 16(4):785-92. PubMed ID: 16029019
    [Abstract] [Full Text] [Related]

  • 9. Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties.
    Mok KW, Lam AM, Cullis PR.
    Biochim Biophys Acta; 1999 Jul 15; 1419(2):137-50. PubMed ID: 10407066
    [Abstract] [Full Text] [Related]

  • 10. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
    Anwer K, Kao G, Proctor B, Rolland A, Sullivan S.
    J Drug Target; 2000 Jul 15; 8(2):125-35. PubMed ID: 10852344
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
    Heyes J, Hall K, Tailor V, Lenz R, MacLachlan I.
    J Control Release; 2006 May 15; 112(2):280-90. PubMed ID: 16603272
    [Abstract] [Full Text] [Related]

  • 12. "Diffusible-PEG-lipid stabilized plasmid lipid particles".
    MacLachlan I, Cullis P.
    Adv Genet; 2005 May 15; 53():157-88. PubMed ID: 16240993
    [Abstract] [Full Text] [Related]

  • 13. Long-circulating vectors for the systemic delivery of genes.
    Fenske DB, MacLachlan I, Cullis PR.
    Curr Opin Mol Ther; 2001 Apr 15; 3(2):153-8. PubMed ID: 11338928
    [Abstract] [Full Text] [Related]

  • 14. Enzyme-responsive destabilization of stabilized plasmid-lipid nanoparticles as an efficient gene delivery.
    Song SJ, Lee S, Lee Y, Choi JS.
    Eur J Pharm Sci; 2016 Aug 25; 91():20-30. PubMed ID: 27240779
    [Abstract] [Full Text] [Related]

  • 15. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
    Reimer DL, Kong S, Monck M, Wyles J, Tam P, Wasan EK, Bally MB.
    J Pharmacol Exp Ther; 1999 May 25; 289(2):807-15. PubMed ID: 10215656
    [Abstract] [Full Text] [Related]

  • 16. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
    Morille M, Montier T, Legras P, Carmoy N, Brodin P, Pitard B, Benoît JP, Passirani C.
    Biomaterials; 2010 Jan 25; 31(2):321-9. PubMed ID: 19800113
    [Abstract] [Full Text] [Related]

  • 17. Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression.
    Ambegia E, Ansell S, Cullis P, Heyes J, Palmer L, MacLachlan I.
    Biochim Biophys Acta; 2005 May 20; 1669(2):155-63. PubMed ID: 15893518
    [Abstract] [Full Text] [Related]

  • 18. Cationic lipid-based delivery system for systemic cancer gene therapy.
    Anwer K, Meaney C, Kao G, Hussain N, Shelvin R, Earls RM, Leonard P, Quezada A, Rolland AP, Sullivan SM.
    Cancer Gene Ther; 2000 Aug 20; 7(8):1156-64. PubMed ID: 10975676
    [Abstract] [Full Text] [Related]

  • 19. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH, Lin YY, Hwang JJ, Wang HE, Tseng YL, Wang SJ, Liu RS, Lin WJ, Yang CS, Ting G.
    Anticancer Res; 2009 Jun 20; 29(6):2111-20. PubMed ID: 19528471
    [Abstract] [Full Text] [Related]

  • 20. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.
    Clark PR, Stopeck AT, Ferrari M, Parker SE, Hersh EM.
    Cancer Gene Ther; 2000 Jun 20; 7(6):853-60. PubMed ID: 10880015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.